Menu
No results found.
Weekly Share Price & Valuation Overview
All Cosmos Bio-Tech Holding Corporation
All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia and internationally. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In addition, the company involved in the research and forest plantation activities; and sale of health care food and cosmetics. All Cosmos Bio-Tech Holding Corporation was founded in 1999 and is headquartered in Pasir Gudang, Malaysia.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
- Negative free cash flow — operations may rely on external financing.
- Market Cap Total equity value of the company (share price × shares outstanding).
- TWD 2.90B
- Enterprise Value Operating value: market cap + total debt − cash.
- TWD 2.70B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- TWD 2.48B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- TWD 690.40M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- TWD 218.99M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- TWD 36.93
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 1.68
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 1.16%
- Shares Outstanding
- 67.24M
- Float Shares
- 25.40M
- Implied Shares Outstanding
- 67.24M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
7.11%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
8.82%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
27.80%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
4.56%
- ROA Return on assets: net income ÷ total assets.
-
2.89%
- ROE Return on equity: net income ÷ shareholder equity.
-
5.18%
- Revenue Growth Year-over-year revenue growth.
-
4.70%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-41.30%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-54.10%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 3.53
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.08
- Total Cash Cash and equivalents.
- TWD 1.10B
- Total Debt Short + long-term interest-bearing debt.
- TWD 260.03M
- Net Debt Net Cash Total debt − cash (negative = net cash).
- TWD -841.48M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 1.19
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- TWD 45.33M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- TWD -351.34M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
1.83%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-14.15%
- Cash Conversion (OpCF/EBITDA)
- 0.21
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.